Chronic diphenhydramine abuse and withdrawal
A diagnostic challenge
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 15, 2016
- Accepted August 10, 2016
- First Published September 14, 2016.
Article Versions
- Previous version (September 14, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Jagroop S. Saran, MD,
- Richard L. Barbano, MD, PhD,
- Rachel Schult, PharmD,
- Timothy J. Wiegand, MD and
- Olga Selioutski, DO
- Jagroop S. Saran, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Richard L. Barbano, MD, PhD,
NONE
NONE
Neurotoxin Association, non-commercial entity: I received travel expenses for workshop presentation. Jagellonian University, Poland: academic institution: I received travel honoraria for lectures/participation in conference
Neurology Clinical Practice, Associate editor, 2011- present
NONE
NONE
NONE
NONE
NONE
I receive stock equity from Visual Dx as Neurology Section Editor
University of Rochester, botulinum toxin injections, 30% effort, since 1994
1. Vaccinex 2.Biotie
NIH, NINDS, ORDR: Dystonia Coalition Projects, Site PI Stock/Stock Options, Medical Equipment & Materials: VisualDx, 2014-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Expert witness in legal proceedings including malpractice, but NOT involving commercial entities
- Rachel Schult, PharmD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Timothy J. Wiegand, MD and
NONE
NONE
NONE
I am an Associate Editor of the Encyclopedia of Toxicology, 3rd Edition. compensation related to editorial position --2012-14.
NONE
UpToDate -Clinical Management of Mushroom Poisoning & Mushroom Poisoning annual royalties.
NONE
Research Abuse Diversion and Addiction Related Surveillance (RADARS) consultant.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Olga Selioutski, DO
NONE
NONE
Presentations on OMED/ AOA and ABONP conferences. I received compensation for travel, hotel stay and honoraria for presentation
NONE
NONE
NONE
NONE
NONE
NONE
Primary investigator for industry sponsored clinical trials supported by SAGE Therapeutics; Sepracor/Sunovion; Bial; Upsher-Smith companies.
NONE
Primary investigator for industry sponsored clinical trials supported by SAGE Therapeutics; Sepracor/Sunovion; Bial; Upsher-Smith companies.
NONE
Adjunct faculty at Genesee Community College Polysomnographic Technology Program since 01/15
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Departments of Anesthesiology (JSS), Neurology (RLB, OS), and Emergency Medicine (RS, TJW), University of Rochester School of Medicine and Dentistry; and Department of Pharmacy (RS), University of Rochester Medical Center, NY.
- Correspondence to:
Jagroop_Saran{at}URMC.rochester.edu
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.